[EN] HYDROPYRIDO[1,2-α]PYRAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE<br/>[FR] COMPOSÉS D'HYDROPYRIDO[1,2-ALPHA]PYRAZINE POUR LE TRAITEMENT D'UNE MALADIE AUTO-IMMUNE
                        
                            
                                申请人:HOFFMANN LA ROCHE
                            
                            
                                公开号:WO2021110614A1
                            
                            
                                公开(公告)日:2021-06-10
                            
                            The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds act as antagonists of the toll-like receptors TLR7, TLR8 and/or TLR9 and are thus useful in the treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
                            本发明涉及式(I)的化合物及其药学上可接受的盐。这些化合物作为toll样受体TLR7、TLR8和/或TLR9的拮抗剂,因此在治疗系统性红斑狼疮(SLE)和狼疮性肾炎方面具有用处。